Work

A Phase 1 Clinical-Pharmacodynamic Study of the Farnesyltransferase Inhibitor Tipifarnib in Combination with the Proteasome Inhibitor Bortezomib in Advanced Acute Leukemias.

Year: 2008

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v112.11.1945.1945

Authors: Jeffrey E. Lancet, Elliott F. Winton, Robert K. Stuart, Michelle Burton, Christopher Cubitt, Michelle Blaskovich, John Wright, Said Sebti, Daniel Sullivan

Institutions: Moffitt Cancer Center, Emory University, Winship Cancer Institute, Medical University of South Carolina, National Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2467225938

FWCI: 0.428

Cites:

Cited by: 2

Related to: 10